Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q2 2024
Institutional positions in Evotec SE as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +8 vs. Q1 2024
- Shares held
- 7.29M
- +2.35M (+47.5%) vs. Q1 2024
- Total value
- $35.0M
- −$3.72M (−9.6%) vs. Q1 2024
- New holders
- 10
- 11 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mubadala Investment Co PJSC | 4,597,701 | $22.1M | 0.09% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,031,576 | $9.75M | 0.00% | +2,031,576 | New |
| Millennium Management LLC | 191,528 | $919.3K | 0.00% | +108,713+131.3% | Added |
| Morgan Stanley | 121,810 | $584.7K | 0.00% | +34,204+39.0% | Added |
| DCF Advisers, LLC | 114,953 | $551.8K | 0.29% | +67,156+140.5% | Added |
| BlackRock Inc. | 82,598 | $396.5K | 0.00% | +44,998+119.7% | Added |
| Goldman Sachs Group Inc | 64,856 | $311.3K | 0.00% | +64,856 | New |
| JustInvest LLC | 19,233 | $87.1K | 0.00% | +19,233 | New |
| Quadrant Capital Group LLC | 14,216 | $68.2K | 0.01% | +7,910+125.4% | Added |
| Mariner, LLC | 12,311 | $58.4K | 0.00% | +12,311 | New |
| Citadel Advisors LLC | 11,444 | $54.9K | 0.00% | +11,444 | New |
| ADAR1 Capital Management, LLC | 9,400 | $45.1K | 0.01% | +1,700+22.1% | Added |
| Bank of America Corp | 5,968 | $28.6K | 0.00% | +1,887+46.2% | Added |
| Signaturefd, LLC | 4,484 | $21.5K | 0.00% | +3,436+327.9% | Added |
| Lindbrook Capital, LLC | 2,088 | $10.0K | 0.00% | +1,784+586.8% | Added |
| Briaud Financial Planning, Inc | 2,160 | $10.0K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 1,698 | $8.15K | 0.00% | +1,122+194.8% | Added |
| Parallel Advisors, LLC | 1,540 | $7.39K | 0.00% | +1,470+2,100.0% | Added |
| UBS Group AG | 1,030 | $4.94K | 0.00% | −736−41.7% | Reduced |
| HHM Wealth Advisors, LLC | 450 | $2.16K | 0.00% | +450 | New |
| Accent Capital Management, LLC | 412 | $1.98K | 0.00% | +412 | New |
| Advisor Group Holdings, Inc. | 332 | $1.59K | 0.00% | +332 | New |
| Clearstead Advisors, LLC | 200 | $960 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 111 | $528 | 0.00% | +111 | New |
| Tower Research Capital LLC (TRC) | 109 | $523 | 0.00% | +109 | New |
| Bell Investment Advisors, Inc | 69 | $332 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 59 | $283 | 0.00% | −658−91.8% | Reduced |
| Royal Bank of Canada | 149 | $0 | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −41,507−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −24,543−100.0% | Sold out |